Project Grant R41HG010978

The Department of the Army Medical Command awarded a $1,093,692.71 Project Grant to HMH Hospitals Corporation, doing business as Hackensack University Medical Center, to support a randomized clinical study of convalescent plasma from recovered COVID-19 donors collected through plasmapheresis as treatment for early COVID-19 infection. The study aims to evaluate the safety and efficacy of convalescent plasma as a treatment option for COVID-19 under the Military Medical Research and Development...

The National Science Foundation awarded a $200,000 Project Grant to the Massachusetts Institute of Technology from April 1, 2021 through March 31, 2022 under the Computer and Information Science and Engineering program. The grant supports research to develop decentralization and privacy technologies for secure vaccination coordination. Specifically, MIT will work on advancing the development of research cyberinfrastructure to enable and accelerate discovery and innovation in computing,...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $295,963 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to New Health Sciences, Inc. (Hemanext Inc.) to evaluate the hemostatic function of platelets stored under hypoxic conditions for whole blood (WB) transfusion. The project aims to develop an improved WB storage platform that maintains an oxygen-managed environment to provide higher quality red blood cells for oxygen delivery and shock reversal, while...

This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...

Grant Award Summary Immunomatics, Inc. received a $207,740 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 15, 2025, with completion targeted for July 31, 2026. The project delivers a machine learning-based prediction model designed to identify permissive human leukocyte antigen (HLA) mismatches in hematopoietic stem cell transplantation (HCT) recipients undergoing posttransplant...

This Project Grant award of $300,000.00 from the National Science Foundation (NSF) Office of Advanced Cyberinfrastructure supports the development of a novel zero-trust and traceable data-sharing infrastructure called WEB3DB. The project aims to address limitations of the current centralized data ecosystem by empowering individuals to control and manage access to their personal health IoT data. Key research outcomes include: (1) novel decentralized identity management and access control...

The National Science Foundation awarded a $393,222 Project Grant to the University of California, Los Angeles under the Engineering federal grant program (CFDA 47.041) on September 15, 2022. The funding will support development of a deep learning-based serological test for point-of-care analysis of COVID-19 immunity using a paper-based multiplexed sensor. Specifically, the university researchers will create a multiplexed vertical flow assay and trained inference network to simultaneously...

Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $2.42 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for research on HIV vaccine development targeting people who inject drugs (PWID). The award, effective from July 1, 2025, through March 31, 2030, supports the development of novel polyvalent HIV vaccines encoding diverse envelope sequences derived from HIV-positive...

Federal Project Grant Award Summary Haima Therapeutics LLC received a $944,676 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 15, 2025, with a completion date of June 30, 2027. The award supports the development and advancement of Synthoplate (SP), a platelet-inspired synthetic hemostatic nanoparticle designed to restore hemostatic function in traumatic brain injury (TBI) patients...

Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Scripps Research Institute a $3.52 million Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) effective September 5, 2025, through June 30, 2030, to support the PLANB2CUREHIV (Plan B Consortium) initiative. The grant funds pre-clinical development of genome-edited B cell-based therapies designed to deliver durable broadly neutralizing antibodies (BNAbs) against HIV. The research involves...